Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHD.L Regulatory News (PHD)

  • There is currently no data for PHD

Director's Dealing

11 Dec 2012 09:21

RNS Number : 2302T
PROACTIS Holdings PLC
11 December 2012
 



 

PROACTIS Holdings PLC

 

("Proactis" or "the Company")

 

Director's Dealing

 

PROACTIS Holdings PLC (AIM: PHD), the specialist Spend Control software provider, announces that it was notified on 10 December 2012 that on that day Rod Jones, CEO, made an in specie transfer of 904,040 ordinary shares of 10 pence each in the share capital of the Company ("Ordinary Shares") from one SIPP account to another.

 

There has been no change in Rod Jones' beneficial holding, which remains at 1,867,720 Ordinary Shares, representing 5.91% of the issued share capital of the Company.

 

 

 

PROACTIS Holdings PLC

Rod Jones, Chief Executive Officer Tel: 01937 545 070

www.proactis.com

 

 

finnCap Limited

Marc Young/Charlotte Stranner Tel: 020 7220 0500

 

 

 

Notes to Editor:

 

PROACTIS creates, sells and maintains specialist software which enables organisations to streamline, control and monitor all internal and external expenditure, other than payroll. PROACTIS is used in over 300 organisations in the UK from the commercial, public and not-for-profit sectors.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSKFLBFLLFLFBB
Date   Source Headline
29th Apr 20217:00 amRNSInterim Results
23rd Mar 20217:00 amRNSContract Win
24th Feb 20217:01 amRNSTrading Update & Notice of Results
24th Feb 20217:00 amRNSbePayd Strategic Contract Win
10th Feb 20217:00 amRNSStrategic Contract Win
8th Jan 202111:15 amRNSHolding(s) in Company
17th Dec 20208:58 amRNSDirector/PDMR Shareholding
14th Dec 20205:19 pmRNSResult of AGM
9th Dec 20207:00 amRNSFirst bePayd contract
7th Dec 20205:00 pmRNSHolding(s) in Company
2nd Dec 20207:00 amRNSNotice of AGM
2nd Dec 20207:00 amRNSDirectorate Change
30th Nov 20207:00 amRNSStrategic Contract Win
19th Nov 20207:00 amRNSDirector/PDMR Shareholding
10th Nov 20205:21 pmRNSHolding(s) in Company
3rd Nov 20205:09 pmRNSHolding(s) in Company
29th Oct 202011:40 amRNSDirector/PDMR Shareholding
29th Oct 20207:00 amRNSFinal Results
19th Oct 20207:00 amRNSStrategic Contract Win
14th Oct 20207:00 amRNSNotice of Results
6th Oct 20205:02 pmRNSHolding(s) in Company
6th Oct 20207:00 amRNSDirectorate Change
1st Oct 20207:00 amRNSDirectorate Change
2nd Sep 20205:07 pmRNSHolding(s) in Company
25th Aug 20207:00 amRNSTrading Update
13th Jul 20205:04 pmRNSHolding(s) in Company
24th Jun 20207:00 amRNSHolding(s) in Company
16th Jun 20206:16 pmRNSHolding(s) in Company
28th May 20208:27 amRNSHolding(s) in Company
27th May 20205:09 pmRNSHolding(s) in Company
22nd May 20207:00 amRNSPerformance Update
21st May 202011:50 amRNSHolding(s) in Company
12th May 20204:40 pmRNSSecond Price Monitoring Extn
12th May 20204:35 pmRNSPrice Monitoring Extension
7th May 20207:00 amRNSHolding(s) in Company
6th May 20205:53 pmEQSForm 8.3 - Proactis Holdings Plc
6th May 20203:42 pmEQSForm 8.3 - Proactis Holdings Plc
6th May 202011:00 amRNSPrice Monitoring Extension
30th Apr 20201:35 pmRNSDirector/PDMR Shareholding
29th Apr 20207:00 amRNSInterim Results
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
28th Apr 20209:05 amRNSSecond Price Monitoring Extn
28th Apr 20209:00 amRNSPrice Monitoring Extension
28th Apr 20207:00 amRNSReset of bank facilities
20th Apr 20207:00 amRNSCOVID-19 Update & Notice of Results
8th Apr 202010:57 amRNSHolding(s) in Company
7th Apr 20204:41 pmRNSSecond Price Monitoring Extn
7th Apr 20204:35 pmRNSPrice Monitoring Extension
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.